News
GSK plc (NYSE:GSK) tops our list for being one of the most undervalued stocks. The company was formerly known as GlaxoSmithKline and is a multinational biopharmaceutical and healthcare company ...
The update includes Pfizer Inc.’s (NYSE:PFE) Abrysvo (Respiratory Syncyt The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday authorized GSK plc’s (NYSE ... British ...
Hosted on MSN22d
Is GSK plc (GSK) an Undervalued Defensive Stock for 2025?Formerly known as GlaxoSmithKline, GSK plc (NYSE:GSK) is a British global pharmaceutical and healthcare company that develops and markets a wide range of medicines, vaccines, and consumer health ...
Investors might consider any price dips as potential entry points. GSK plc, formerly known as GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company headquartered ...
MONTRÉAL, March 25, 2025 /CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (PFE) and Shionogi as shareholders, is pleased to ...
GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is ...
GlaxoSmithKline (GSK) has accelerated the review of its Horlicks ... few bidders such as PepsiCo Inc and Reckitt Benckiser Group Plc. Reuters sources also list Nestlé, the world’s biggest ...
MANILA, Philippines — GSK plc (LSE/NYSE: GSK ... Editor’s Note: This press release is sponsored by GlaxoSmithKline Philippines. It is published by the Advertising Content Team that is ...
Inc., and Vice President at GSK plc (formerly GlaxoSmithKline plc) and Kos Pharmaceuticals, Inc. Notable achievements include building an $800M division at Kos Pharmaceuticals, Inc., helping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results